- The global blood plasma market is largely shaped by the expanding use of plasma-derived therapies, which are crucial for treating a variety of chronic and rare medical conditions. For instance, therapies such as immunoglobulins and clotting factors have become essential in managing diseases such as immune deficiencies and bleeding disorders
- Increasing awareness among healthcare professionals and patients about the benefits and applications of plasma-derived treatments is influencing the market dynamics significantly. Educational campaigns and clinical research have enhanced understanding of how these therapies can improve quality of life for individuals with complex conditions
- North America dominates the blood plasma market with share of 47.05% in 2024, driven by a well-established healthcare infrastructure and high adoption of advanced plasma therapies
- Asia-pacific is expected to be the fastest growing region in the blood plasma market during the forecast period due to rising healthcare expenditures, growing awareness of plasma therapies, and expanding patient pools across emerging economies are key drivers
- The immunoglobulin segment dominates the largest market share with 45.09% in 2024, due to its widespread application in treating immune deficiencies and autoimmune diseases
